Biogen (BIIB) Operating Leases (2019 - 2026)
Biogen's Operating Leases was $264.8 million in Q2 2026, down 14.8% from $310.9 million a year earlier and down 3.1% from the prior quarter.
Powered by 
Analysis
Biogen (BIIB) Operating Leases (2019 - 2026) Analysis & Trends
At the end of FY2025, Operating Leases at Biogen came in at $290.4 million, down 13.2% from FY2024.
- Operating Leases shows a five-year compound annual growth rate of -6.3% (FY2020 to FY2025).
- In earlier years, Operating Leases was $334.5 million in FY2024 (-16.4%), $400 million in FY2023 (+20.1%), $333 million in FY2022 (+0.8%) and $330.4 million in FY2021 (-17.8%).
- The Q2 2026 figure marks the lowest quarterly Operating Leases in data going back to Q1 2019.
- Compared with a year earlier, Operating Leases has declined for eight straight quarters, with an average decline of 15.9% over the last eight quarters.
- The best year-over-year quarter for Operating Leases over five years was Q1 2024 (growth of 24.3%); the worst was Q2 2022 (a decline of 24.6%).
- Per Business Quant data, BIIB's Operating Leases in the three quarters before Q2 2026 was $273.4 million (Q1 2026), $290.4 million (Q4 2025) and $305 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,140.19 Bn | 1,108.77 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 634.59 Bn | 554.45 Bn | 17.30 Bn |
| 3 | AbbVie | 499.62 Bn | 472.73 Bn | 12.70 Bn |
| 4 | Merck | 354.90 Bn | 309.28 Bn | 12.21 Bn |
| 5 | Novartis Ag | 300.00 Bn | 263.99 Bn | 11.24 Bn |
| 6 | Astrazeneca | 263.32 Bn | 237.01 Bn | 12.86 Bn |
| 7 | Amgen | 238.09 Bn | 193.49 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 193.99 Bn | 168.19 Bn | 6.22 Bn |
| 9 | Pfizer | 170.34 Bn | 116.99 Bn | 10.94 Bn |
| 10 | Biogen | 36.54 Bn | 23.19 Bn | 1.96 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 264.80 Mn |
| Mar 31, 2026 | 273.40 Mn |
| Dec 31, 2025 | 290.40 Mn |
| Sep 30, 2025 | 305.00 Mn |
| Jun 30, 2025 | 310.90 Mn |
| Mar 31, 2025 | 323.40 Mn |
| Dec 31, 2024 | 334.50 Mn |
| Sep 30, 2024 | 357.00 Mn |
| Jun 30, 2024 | 367.50 Mn |
| Mar 31, 2024 | 406.50 Mn |
| Dec 31, 2023 | 400.00 Mn |
| Sep 30, 2023 | 428.80 Mn |
| Jun 30, 2023 | 304.40 Mn |
| Mar 31, 2023 | 327.00 Mn |
| Dec 31, 2022 | 333.00 Mn |
| Sep 30, 2022 | 354.80 Mn |
| Jun 30, 2022 | 274.20 Mn |
| Mar 31, 2022 | 312.30 Mn |
| Dec 31, 2021 | 330.40 Mn |
| Sep 30, 2021 | 348.20 Mn |
API Access
Biogen Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=BIIB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "BIIB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=BIIB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();